Basal Ganglia Pathophysiology

161 – 170 of 196

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/V1000356?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2006
Mark Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
Cenci Nilsson, Angela ^LU and Lundblad, Martin ^LU (2006) In Journal of Neurochemistry 99(2). p.381-392
- Contribution to journal › Article
Mark Mechanisms of L-DOPA-induced dyskinesia in Parkinson´s disease: What do animal models tell us?
Cenci Nilsson, Angela ^LU (2006) p.351-360
- Chapter in Book/Report/Conference proceeding › Book chapter
Mark Dyskinesia and neural grafting in Parkinson's disease
Cenci Nilsson, Angela ^LU and Hagell, Peter ^LU (2006) p.184-224
- Chapter in Book/Report/Conference proceeding › Book chapter
2005
Mark The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
Björkqvist, Maria ^LU ; Fex, Malin ^LU ; Renström, Erik ^LU ; Wierup, Nils ^LU ; Petersén, Åsa ^LU ; Gil, Joana ^LU ; Bacos, Karl ^LU ; Popovic, Natalija ^LU ; Li, Jia-Yi ^LU and Sundler, Frank ^LU , et al. (2005) In Human Molecular Genetics 14(5). p.565-574
- Contribution to journal › Article
Mark Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective.
Hagell, Peter ^LU and Cenci Nilsson, Angela ^LU (2005) In Brain Research Bulletin 68(1-2). p.4-15
- Contribution to journal › Article
Mark Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
Lundblad, Martin ^LU ; Usiello, A ; Carta, Manolo ^LU ; Håkansson, Katarina ; Fisone, G and Cenci Nilsson, Angela ^LU (2005) In Experimental Neurology 194(1). p.66-75
- Contribution to journal › Article
Mark Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease.
Papalexi, Eugenia ^LU ; Persson, Anna ^LU ; Björkqvist, Maria ^LU ; Petersén, Åsa ^LU ; Woodman, Ben ; Bates, Gillian P ; Sundler, Frank ^LU ; Mulder, Hindrik ^LU ; Brundin, Patrik ^LU and Popovic, Natalija ^LU (2005) In European Journal of Neuroscience 22(6). p.1541-1546
- Contribution to journal › Article
Mark Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.
Carlsson, Thomas ^LU ; Winkler, Christian ^LU ; Burger, Corinna ; Muzyczka, Nicholas ; Mandel, Ronald J ; Cenci Nilsson, Angela ^LU ; Björklund, Anders ^LU and Kirik, Deniz ^LU (2005) In Brain 128(3). p.559-569
- Contribution to journal › Article
Mark Orexin loss in Huntington's disease.
Petersén, Åsa ^LU ; Gil, Joana ^LU ; Maat-Schieman, Marion L C ; Björkqvist, Maria ^LU ; Tanila, Heikki ; Araújo, Ines M ; Smith, Ruben ^LU ; Popovic, Natalija ^LU ; Wierup, Nils ^LU and Norlén, Per ^LU , et al. (2005) In Human Molecular Genetics 14(1). p.39-47
- Contribution to journal › Article
Mark Chapte B7 - Utility of 6-hydroxydopamine lesioned rats in the preclinical screening of novel treatments for Parkinson disease
Cenci Nilsson, Angela ^LU and Lundblad, Martin ^LU (2005) p.193-208
- Chapter in Book/Report/Conference proceeding › Book chapter